TCDA Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 35.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Tricida Insider Trading History Chart

This chart shows the insider buying and selling history at Tricida by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$5M$0$5MTotal Insider BuyingTotal Insider Selling

Tricida Share Price & Price History

Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 01/23/2023 05:00 PM ET

This chart shows the closing price history over time for TCDA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

SEC Filings (Institutional Ownership Changes) for Tricida (NASDAQ:TCDA)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TCDA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1$0Total InflowsTotal Outflows
Tricida logo
Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in South San Francisco, CA.
Read More on Tricida

Today's Range

Now: N/A

50 Day Range

MA: $0.13
Low: $0.11
High: $0.19

52 Week Range

Now: N/A

Volume

31,125,300 shs

Average Volume

17,618,414 shs

Market Capitalization

$6.01 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.22